28 related articles for article (PubMed ID: 10697434)
1. Prolidase activity assays. A survey of the reported literature methodologies.
Fiorito S; Genovese S; Epifano F; Collevecchio C
Anal Biochem; 2024 Jun; 689():115506. PubMed ID: 38460899
[TBL] [Abstract][Full Text] [Related]
2. Prolidase as a prodrug converting enzyme I. Synthesis of proline analogue of chlorambucil and its susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1997; 42(1):148-55. PubMed ID: 9581474
[TBL] [Abstract][Full Text] [Related]
3. Prolidase as a prodrug converting enzyme. II. Synthesis of proline analogue of anthraquinone-2-carboxylic acid and its susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1998; 43():201-9. PubMed ID: 9972056
[TBL] [Abstract][Full Text] [Related]
4. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
[TBL] [Abstract][Full Text] [Related]
5. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase.
Bielawska A; Chrzanowski K; Bielawski K; Pałka J
Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665
[TBL] [Abstract][Full Text] [Related]
6. Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
Chrzanowski K; Pałka J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():209-11. PubMed ID: 11820612
[TBL] [Abstract][Full Text] [Related]
7. Prolidase as a prodrug converting enzyme. III. Synthesis of proline analogues of melphalan and theirs susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1999; 44():190-9. PubMed ID: 10697434
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule based delivery systems for alkylating antineoplastic compounds.
Bielawski K; Bielawska A
ChemMedChem; 2008 Apr; 3(4):536-42. PubMed ID: 18157855
[TBL] [Abstract][Full Text] [Related]
9. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations.
Lupi A; Tenni R; Rossi A; Cetta G; Forlino A
Amino Acids; 2008 Nov; 35(4):739-52. PubMed ID: 18340504
[TBL] [Abstract][Full Text] [Related]
10. Biotechnological applications of recombinant microbial prolidases.
Theriot CM; Tove SR; Grunden AM
Adv Appl Microbiol; 2009; 68():99-132. PubMed ID: 19426854
[TBL] [Abstract][Full Text] [Related]
11. Virus-directed enzyme prodrug therapy using CB1954.
Grove JI; Searle PF; Weedon SJ; Green NK; McNeish IA; Kerr DJ
Anticancer Drug Des; 1999 Dec; 14(6):461-72. PubMed ID: 10834268
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-catalyzed activation of anticancer prodrugs.
Rooseboom M; Commandeur JN; Vermeulen NP
Pharmacol Rev; 2004 Mar; 56(1):53-102. PubMed ID: 15001663
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
